Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Brooks Laboratories Ltd
Brooks Laboratories Ltd

Brooks Laboratories Ltd (BROOKS) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 28,875
Dec 05, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹97.82
₹-0.68 (-0.69%)
96.26Low
Today’s Performance
102.60High
95.25Low
52 Week’s Performance
198.86High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-0.69%
  • 1 Week-4.29%
  • 1 Month-7.02%
  • 3 Months-35.24%
  • 6 Months-29.38%
  • 1 Year-28.07%
  • 3 Years-6.03%
  • 5 Years7.70%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta1.03
  • 52-Week Low (₹)95.25
  • 52-Week High (₹)198.86
  • Price-to-Book (X)*2.53
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*20.98
  • Earnings Per Share (₹)4.74
  • Market Cap (₹ Cr.)*288.15
* Values as of last close price

bt_logoCOMPETITORS

BT TV

"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
View more

bt_logoFAQ's

What was Brooks Laboratories Ltd share price previously?
Brooks Laboratories Ltd share price was down by -0.69% from the previous closing price of ₹98.50.
Who are peers of Brooks Laboratories Ltd?
The peers of Brooks Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Brooks Laboratories Ltd?
The promotor/promotors of Brooks Laboratories Ltd are Jitendra Pratap Singh, Durga Sankar Maity, Mr. Bhushan Singh Rana, Lalit Mahajan, Usha Singh, Manav Mahajan.
What has been 52-week high of Brooks Laboratories Ltd stocks?
The highest price of Brooks Laboratories Ltd stock is ₹198.86 in the last 52-week.
What is the share price of Brooks Laboratories Ltd (BROOKS) today on NSE?
As on Dec 05, 2025 Brooks Laboratories Ltd (BROOKS)’s share price on NSE is Rs 97.82
What is the market cap of Brooks Laboratories Ltd (BROOKS)?
The current market capitalisation of Brooks Laboratories Ltd (BROOKS) is 288.15 crores
What is Brooks Laboratories Ltd Share symbol?
The symbol of Brooks Laboratories Ltd is BROOKS.
What is the PE ratio of Brooks Laboratories Ltd (BROOKS)?
The current PE ratio of Brooks Laboratories Ltd (BROOKS) is 20.98.
What is the PB ratio of Brooks Laboratories Ltd (BROOKS)?
The current PB ratio of Brooks Laboratories Ltd (BROOKS) is 2.53.
Today’s High & Low share prices of Brooks Laboratories Ltd (BROOKS) on NSE?
Today, the share price of Brooks Laboratories Ltd (BROOKS) on NSE touched a high of Rs 102.6 and a low of Rs 96.26
What price did Brooks Laboratories Ltd (BROOKS) shares open on the NSE today?
On NSE, the share price of Brooks Laboratories Ltd (BROOKS) opened at Rs 97.9
What is the 52-week high of Brooks Laboratories Ltd (BROOKS)?
The 52-week high price of Brooks Laboratories Ltd (BROOKS) is Rs 198.86
What is the 52-week low of Brooks Laboratories Ltd (BROOKS)?
The 52-week low price of Brooks Laboratories Ltd (BROOKS) is Rs 95.25

bt_logoAbout Brooks Lab.

Brooks Laboratories Ltd, incorporated in the year 2002, has its registered office in Village Kishanpura, Nilagarh Road Baddi, Solan, Himachal Pradesh, 174101, 91-1795-654001/02/03, 91-1795-236939. The main industry in which Brooks Laboratories Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Brooks Laboratories Ltd is/are DMKH & Co. In the main management, is chairman and is the company secretary for Brooks Laboratories Ltd.

  • JPS
    Jitendra Pratap SinghWhole Time Director
  • DSM
    Durga Sankar MaityWhole-time Director
  • MBSR
    Mr. Bhushan Singh RanaWhole-time Director
  • LM
    Lalit MahajanIndependent Director
  • US
    Usha SinghIndependent Director
  • MM
    Manav MahajanIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.